Search research articles
Contact Us
Filters
Showing results (71-80 of 143) with videos related to
Page
of 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2005
Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients
Mitchell Ho, Raffit Hassan, Jingli Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 21, 2005
Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy
Satoshi Nagata, Tomoko Ise, Masanori Onda, et al.
Molecular Cancer Therapeutics
|
May 7, 2009
A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity
Yang Feng, Xiaodong Xiao, Zhongyu Zhu, et al.
Scientific Reports
|
May 22, 2015
New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma
Yi-Fan Zhang, Yen Phung, Wei Gao, et al.
The Analyst
|
October 23, 2010
High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array
Yi-Chung Tung, Amy Y Hsiao, Steven G Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2006
Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma
Masanori Onda, Satoshi Nagata, Mitchell Ho, et al.
Hepatology (Baltimore, Md.)
|
February 5, 2014
Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy
Wei Gao, Heungnam Kim, Mingqian Feng, et al.
Hepatology Communications
|
January 16, 2026
Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinoma
Jinchutha Duangdara, Shaoli Lin, Jessica Hong, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
Temporal mapping of the anti-tumor effects of nanobody-based MSLN.CAR-T cell therapy in metastatic solid tumors
Chaido Stathopoulou, Mingming Zhao, Qun Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
Mesothelin expression in human lung cancer
Mitchell Ho, Tapan K Bera, Mark C Willingham, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 143) with videos related to
Sort By:
Page
of 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2005
Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients
Mitchell Ho, Raffit Hassan, Jingli Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 21, 2005
Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy
Satoshi Nagata, Tomoko Ise, Masanori Onda, et al.
Molecular Cancer Therapeutics
|
May 7, 2009
A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity
Yang Feng, Xiaodong Xiao, Zhongyu Zhu, et al.
Scientific Reports
|
May 22, 2015
New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma
Yi-Fan Zhang, Yen Phung, Wei Gao, et al.
The Analyst
|
October 23, 2010
High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array
Yi-Chung Tung, Amy Y Hsiao, Steven G Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2006
Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma
Masanori Onda, Satoshi Nagata, Mitchell Ho, et al.
Hepatology (Baltimore, Md.)
|
February 5, 2014
Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy
Wei Gao, Heungnam Kim, Mingqian Feng, et al.
Hepatology Communications
|
January 16, 2026
Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinoma
Jinchutha Duangdara, Shaoli Lin, Jessica Hong, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
Temporal mapping of the anti-tumor effects of nanobody-based MSLN.CAR-T cell therapy in metastatic solid tumors
Chaido Stathopoulou, Mingming Zhao, Qun Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
Mesothelin expression in human lung cancer
Mitchell Ho, Tapan K Bera, Mark C Willingham, et al.
Page
of 15